The Utilization and Impact of Dopamine Transporter Imaging in Diagnosing Movement Disorders at a Tertiary Care Hospital in Greece.

ABSTRACT: Background/Objectives: The introduction of dopamine transporter scan (DaTscan) in clinical diagnostics has revolutionized the way clinicians approach movement disorders, offering valuable insights into presynaptic striatal dopaminergic deficits and revealing subjacent neurodegeneration. The aim of our study was to evaluate the impact of DaTscan on diagnostic decisions regarding movement disorders, particularly Parkinson's disease (PD) and atypical parkinsonian syndromes, under real-world circumstances in Greece. Methods: We retrospectively analyzed data from 360 patients who underwent a DaTscan examination between 2018 and 2023 at a tertiary hospital in Greece, including referrals from both movement disorder specialists and general neurologists, either hospital-based or in pr

SUBMITTER: Xiromerisiou G 

PROVIDER: S-EPMC12024717 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature